Finance

Transdermal science-focused company reports first quarter 2005 financial results

Published in Obesity and Diabetes Week, June 6th, 2005

Sontra Medical Corporation (SONT) announced financial results for the first quarter ended March 31, 2005.

For the 3 months ended March 31, 2005, the net loss applicable to common stockholders was $1,293,000, or $.06 per share, as compared to $1,403,000, or $.11 per share, for the same period in 2004.

The company ended the quarter with $7,892,000 in cash and short term investments. The company expects that its cash and short term investments on hand will be sufficient to fund operations through at least June, 2006.

Among the highlights reported for the first quarter, is that SonoPrep and the procedure tray for topical lidocaine...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week

Source: Obesity and Diabetes Week (2005-06-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry